PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Appointment of Mr. Samir Kazi as an Executive Director. PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Resignation of Mr. Vivek Dhariwal - Executive Director - Technical Operations Pfizer Ltd - 500680 - Unaudited Financial Results For The Quarter Ended December 31, 2019.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended December 31, 2019, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 2:00 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record. Pfizer Ltd - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates Pfizer Ltd - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates Earnings Call Transcript - Pfizer
Full Earnings Transcript: Conference Call between Management and Analysts (Company Q4 ends December '19) Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended December 31, 2019.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 14, 2020, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2019. Pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company remains closed from Wednesday, January 1, 2020 till 48 hours after the results are made public on February 14, 2020. We request you to kindly take the same on record. Pfizer Ltd - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates